These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polycythemia vera: a review. Golden C. Clin J Oncol Nurs; 2003 Feb; 7(5):553-6. PubMed ID: 14603552 [Abstract] [Full Text] [Related]
3. Diagnosis and therapy of polycythemia vera. Lengfelder E, Merx K, Hehlmann R. Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281 [Abstract] [Full Text] [Related]
4. Polycythemia vera. Stuart BJ, Viera AJ. Am Fam Physician; 2004 May 01; 69(9):2139-44. PubMed ID: 15152961 [Abstract] [Full Text] [Related]
5. Contemporary approach to essential thrombocythemia and polycythemia vera. Aruch D, Mascarenhas J. Curr Opin Hematol; 2016 Mar 01; 23(2):150-60. PubMed ID: 26717193 [Abstract] [Full Text] [Related]
6. From leeches to personalized medicine: evolving concepts in the management of polycythemia vera. Vannucchi AM. Haematologica; 2017 Jan 01; 102(1):18-29. PubMed ID: 27884974 [Abstract] [Full Text] [Related]
7. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Semin Hematol; 1986 Apr 01; 23(2):132-43. PubMed ID: 3704665 [Abstract] [Full Text] [Related]
8. [Effect of bloodletting on the proliferative activity of erythroid progenitor cells from the bone marrow of patients with polycythemia and polycythemia vera]. Hansz J, Kozłowska-Skrzypczak M. Pol Arch Med Wewn; 1991 Sep 01; 86(3):125-31. PubMed ID: 1808597 [Abstract] [Full Text] [Related]
9. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Tefferi A. Am J Hematol; 2012 Mar 01; 87(3):285-93. PubMed ID: 22331582 [Abstract] [Full Text] [Related]
13. A contemporary approach to the diagnosis and management of polycythemia vera. Tefferi A. Curr Hematol Rep; 2003 May 07; 2(3):237-41. PubMed ID: 12901345 [Abstract] [Full Text] [Related]
14. 5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy. Lerner J, Michel M, Dasanu CA. J Oncol Pharm Pract; 2020 Jul 07; 26(5):1285-1288. PubMed ID: 32054413 [Abstract] [Full Text] [Related]
15. Polycythaemia vera and essential thrombocythaemia: current treatment strategies. Penninga EI, Bjerrum OW. Drugs; 2006 Jul 07; 66(17):2173-87. PubMed ID: 17137402 [Abstract] [Full Text] [Related]
16. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data. Finazzi G. Semin Thromb Hemost; 2006 Apr 07; 32(3):276-82. PubMed ID: 16673282 [Abstract] [Full Text] [Related]
18. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Tefferi A. Am J Hematol; 2013 Jun 07; 88(6):507-16. PubMed ID: 23695894 [Abstract] [Full Text] [Related]
19. Polycythemia vera. Murphy S. Dis Mon; 1992 Mar 07; 38(3):153-212. PubMed ID: 1587207 [Abstract] [Full Text] [Related]
20. New Therapeutic Approaches in Polycythemia Vera. Falchi L, Newberry KJ, Verstovsek S. Clin Lymphoma Myeloma Leuk; 2015 Jun 07; 15 Suppl(0):S27-33. PubMed ID: 26297275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]